Yaxia Yuan

Yaxia Yuan

University of Florida

H-index: 21

North America-United States

About Yaxia Yuan

Yaxia Yuan, With an exceptional h-index of 21 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Florida, specializes in the field of Drug design, MD simulation, PROTACs, Molecular glue.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL

Design and synthesis of indol-2-one derivatives as potential RET inhibitors

TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells

Therapeutic agents and methods of treatment

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis

Synthesis-accessibility-oriented design of c-Jun N-terminal kinase 1 inhibitor

Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism

Piperlongumine conjugates induce targeted protein degradation

Yaxia Yuan Information

University

Position

___

Citations(all)

2353

Citations(since 2020)

1857

Cited By

996

hIndex(all)

21

hIndex(since 2020)

19

i10Index(all)

37

i10Index(since 2020)

33

Email

University Profile Page

Google Scholar

Yaxia Yuan Skills & Research Interests

Drug design

MD simulation

PROTACs

Molecular glue

Top articles of Yaxia Yuan

Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL

Nature communications

2024/3/29

Design and synthesis of indol-2-one derivatives as potential RET inhibitors

Bioorganic & Medicinal Chemistry Letters

2023/12/15

TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells

Nucleic acids research

2023/12/11

Therapeutic agents and methods of treatment

2023/10/26

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis

Molecular oncology

2023/10/19

Synthesis-accessibility-oriented design of c-Jun N-terminal kinase 1 inhibitor

European Journal of Medicinal Chemistry

2023/8/5

Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism

Signal transduction and targeted therapy

2023/2/27

DyScore: A boosting scoring method with dynamic properties for identifying true binders and nonbinders in structure-based drug discovery

Journal of chemical information and modeling

2022/11/3

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Cancer research

2022/10/17

Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function

Plos one

2022/9/28

Replenishing HDL with synthetic HDL has multiple protective effects against sepsis in mice

Science signaling

2022/3/15

Identification of Piperlongumine (PL) as a new E3 ligase ligand to induce targeted protein degradation

Cell Chemical Biology

2022/1/23

Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport

Journal of Neuroimmune Pharmacology

2021/12/1

Creation of an anti-inflammatory, leptin-dependent anti-obesity celastrol mimic with better druggability

Frontiers in Pharmacology

2021/8/30

Binding mode of human norepinephrine transporter interacting with HIV-1 tat

ACS chemical neuroscience

2021/4/22

Multiple Target Drug Design Using LigBuilder 3

Protein-Ligand Interactions and Drug Design

2021

Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines

European journal of medicinal chemistry

2020/8/1

See List of Professors in Yaxia Yuan University(University of Florida)